Adaptogenic pathway

The "adaptogenic pathway" refers to the broad, interconnected network of cellular signaling, gene regulation, and physiological responses modulated by adaptogen compounds. Adaptogens, which include certain botanical extracts, are not single-target drugs but modulate multiple molecular pathways involved in the body’s stress response, particularly the neuroendocrine-immune axis. These compounds enhance non-specific resistance to stress by activating homeostatic and adaptive processes at the molecular and cellular level, such as the HPA (hypothalamic-pituitary-adrenal) axis, protein kinases, and heat shock proteins. Because of their pleiotropic, multitarget action, the adaptogenic pathway is a conceptual, not a discrete, molecular drug target, and should not be regarded as a standard receptor or enzyme. The term "adaptogenic pathway" is scientifically imprecise as a molecular target; “adaptogen” refers to a pharmacological category of agents and their broad, multi-pathway modes of action. Adaptogens modulate several targets and pathways but "adaptogenic pathway" is not a recognized drug discovery target or therapeutic molecular entity.

Other names

Adaptogenic systemadaptogenic signalingadaptogen-mediated pathways

Modulation of neuroendocrine-immune system; Regulation of stress hormones (e.g., corticotropin-releasing hormone); Activation of adaptive stress response signaling pathways (such as cAMP-mediated pathways, protein kinase A, Hsp70/72 induction); Enhancement of gene expression related to cellular stress adaptation; Multi-targeted stress-mimetic effects